B. Riley Wealth Advisors Inc. Sells 280 Shares of Crocs, Inc. (NASDAQ:CROX)

B. Riley Wealth Advisors Inc. lessened its stake in shares of Crocs, Inc. (NASDAQ:CROXFree Report) by 8.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,176 shares of the textile maker’s stock after selling 280 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Crocs were worth $297,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Byrne Asset Management LLC boosted its stake in shares of Crocs by 60.0% during the 4th quarter. Byrne Asset Management LLC now owns 320 shares of the textile maker’s stock worth $30,000 after acquiring an additional 120 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Crocs by 185.0% during the 4th quarter. Blue Trust Inc. now owns 342 shares of the textile maker’s stock worth $32,000 after acquiring an additional 222 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Crocs during the 4th quarter worth about $53,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Crocs during the 4th quarter worth about $56,000. Finally, Manchester Capital Management LLC boosted its stake in shares of Crocs by 1,673.5% during the 4th quarter. Manchester Capital Management LLC now owns 603 shares of the textile maker’s stock worth $56,000 after acquiring an additional 569 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CROX shares. OTR Global upgraded Crocs from a “mixed” rating to a “positive” rating in a research note on Thursday, April 11th. Williams Trading restated a “hold” rating and set a $125.00 target price (down previously from $135.00) on shares of Crocs in a research note on Tuesday, April 16th. UBS Group increased their target price on Crocs from $124.00 to $148.00 and gave the company a “neutral” rating in a research note on Wednesday, May 8th. Barclays increased their target price on Crocs from $167.00 to $169.00 and gave the company an “overweight” rating in a research note on Wednesday, May 8th. Finally, KeyCorp increased their target price on Crocs from $130.00 to $149.00 and gave the company an “overweight” rating in a research note on Thursday, March 21st. Four investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $154.83.

Check Out Our Latest Analysis on Crocs

Insider Transactions at Crocs

In other news, Director Thomas J. Smach sold 10,174 shares of the stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $140.32, for a total value of $1,427,615.68. Following the completion of the transaction, the director now directly owns 115,339 shares of the company’s stock, valued at approximately $16,184,368.48. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, EVP Shannon Sisler sold 1,450 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $152.32, for a total value of $220,864.00. Following the completion of the transaction, the executive vice president now directly owns 35,653 shares of the company’s stock, valued at approximately $5,430,664.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Thomas J. Smach sold 10,174 shares of the stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $140.32, for a total value of $1,427,615.68. Following the sale, the director now owns 115,339 shares in the company, valued at $16,184,368.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,178 shares of company stock valued at $4,597,445. Corporate insiders own 2.72% of the company’s stock.

Crocs Trading Down 1.7 %

Crocs stock opened at $148.64 on Thursday. The business has a 50 day moving average price of $142.99 and a two-hundred day moving average price of $124.34. The company has a quick ratio of 1.14, a current ratio of 1.76 and a debt-to-equity ratio of 1.08. The stock has a market cap of $9.02 billion, a price-to-earnings ratio of 11.50, a price-to-earnings-growth ratio of 1.69 and a beta of 1.97. Crocs, Inc. has a 12 month low of $74.00 and a 12 month high of $165.32.

Crocs (NASDAQ:CROXGet Free Report) last issued its earnings results on Tuesday, May 7th. The textile maker reported $3.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.25 by $0.77. Crocs had a return on equity of 56.33% and a net margin of 19.80%. The business had revenue of $938.60 million during the quarter, compared to analysts’ expectations of $884.29 million. During the same period in the prior year, the firm posted $2.61 EPS. Crocs’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, equities analysts forecast that Crocs, Inc. will post 12.66 EPS for the current year.

Crocs Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Recommended Stories

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.